Synth Logo

Get a high resolution logo for any domain or stock ticker — for free

Alpha Cognition Inc. (ACOGD) logo

PNG 3.32 KB
Download
https://logo.synthfinance.com/ticker/ACOGD
HTML
<img src="https://logo.synthfinance.com/ticker/ACOGD" />
About Alpha Cognition Inc. (ACOGD)

Alpha Cognition Inc., a clinical stage biopharmaceutical company, develops treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Industry

Biotechnology

Sector

Healthcare